289631-40-9

Upstream product

• 289631-32-9 C₆₇H₁₁₂O₁₇Si₂ 
• 289631-30-7 C₆₇H₁₁₄O₁₇Si₂ 
• 289631-34-1 C₆₁H₉₈O₁₇Si 
• 252006-20-5 (2S,3S,4S,5S,6E,8S,9Z)-4-(tert-butyldimethylsilyloxymethyl)-3-(3,4-dimethoxybenzyloxy)-5-methoxymethoxy-2,6,8-trimethyl-6,9-undecadienal 
• 226079-49-8 (3S,4E,6R,7S,8S,9R,10S,11S)-12-triethylsilyloxy-8,10-<(S)-3,4-dimethoxybenzylidenedioxy>-6,11-bis(methoxymethoxy)-3,5,7,9-tetramethyl-4-dodecen-2-one 
• 289631-38-5 C₆₁H₉₆O₁₇Si 

Downstream Products

• 289631-29-4 C₅₅H₈₂O₁₈ 

Relevant academic research and scientific papers

Synthetic studies of an 18-membered antitumor macrolide, tedanolide. 6. Synthesis of a key intermediate via a highly efficient macrolactonization of a computer-aid designed seco-acid

A stereoselective synthesis is described of the 18-membered lactone (2) via an efficient macrolactonization of the conformation-controlled seco-acid (3); this was designed with the aid of molecular mechanics (MM)-calculation and synthesized by coupling between the C1 - C12 (4) and C13 - C23 (5) fragments.